Anti–SARS-CoV-2 spike protein S1 receptor-binding domain antibody after vaccination with inactivated whole-virus SARS-CoV-2 in end-stage kidney disease patients: an initial report

Sarinya BoongirdPiyatida ChuengsamanSalinnart PhanprasertRungthiwa KitpermkiatMontira AssanathamArkom NongnuchSasisopin KiertiburanakulKumthorn MalathumAngsana PhuphuakratChavachol SetthaudomJackrapong BruminhentFaculty of Medicine Ramathibodi Hospital, Mahidol UniversityBanphaeo Hospital2022-08-042022-08-042021-11-01Kidney International. Vol.100, No.5 (2021), 1136-113815231755008525382-s2.0-85116861871https://repository.li.mahidol.ac.th/handle/20.500.14594/77722Mahidol UniversityMedicineAnti–SARS-CoV-2 spike protein S1 receptor-binding domain antibody after vaccination with inactivated whole-virus SARS-CoV-2 in end-stage kidney disease patients: an initial reportLetterSCOPUS10.1016/j.kint.2021.08.007